Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2014 2
2015 3
2016 3
2017 3
2018 1
2019 3
2020 2
2021 3
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Analysis of Intrinsic Breast Cancer Subtypes: The Clinical Utility of Epigenetic Biomarkers and TP53 Mutation Status in Triple-Negative Cases.
Sadzeviciene I, Snipaitiene K, Scesnaite-Jerdiakova A, Daniunaite K, Sabaliauskaite R, Laurinaviciene A, Drobniene M, Ostapenko V, Jarmalaite S. Sadzeviciene I, et al. Among authors: daniunaite k. Int J Mol Sci. 2022 Dec 6;23(23):15429. doi: 10.3390/ijms232315429. Int J Mol Sci. 2022. PMID: 36499753 Free PMC article.
Decreased expression of MT1E is a potential biomarker of prostate cancer progression.
Demidenko R, Daniunaite K, Bakavicius A, Sabaliauskaite R, Skeberdyte A, Petroska D, Laurinavicius A, Jankevicius F, Lazutka JR, Jarmalaite S. Demidenko R, et al. Among authors: daniunaite k. Oncotarget. 2017 Jun 27;8(37):61709-61718. doi: 10.18632/oncotarget.18683. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 28977898 Free PMC article.
The utility of urine-circulating miRNAs for detection of prostate cancer.
Stuopelyte K, Daniunaite K, Bakavicius A, Lazutka JR, Jankevicius F, Jarmalaite S. Stuopelyte K, et al. Among authors: daniunaite k. Br J Cancer. 2016 Sep 6;115(6):707-15. doi: 10.1038/bjc.2016.233. Epub 2016 Aug 4. Br J Cancer. 2016. PMID: 27490805 Free PMC article. Clinical Trial.
Detection of miRNAs in urine of prostate cancer patients.
Stuopelytė K, Daniūnaitė K, Jankevičius F, Jarmalaitė S. Stuopelytė K, et al. Among authors: daniunaite k. Medicina (Kaunas). 2016;52(2):116-24. doi: 10.1016/j.medici.2016.02.007. Epub 2016 Mar 11. Medicina (Kaunas). 2016. PMID: 27170485 Free article.
Frequent down-regulation of ABC transporter genes in prostate cancer.
Demidenko R, Razanauskas D, Daniunaite K, Lazutka JR, Jankevicius F, Jarmalaite S. Demidenko R, et al. Among authors: daniunaite k. BMC Cancer. 2015 Oct 12;15:683. doi: 10.1186/s12885-015-1689-8. BMC Cancer. 2015. PMID: 26459268 Free PMC article.
Epigenetic regulation of human adipose-derived stem cells differentiation.
Daniunaite K, Serenaite I, Misgirdaite R, Gordevicius J, Unguryte A, Fleury-Cappellesso S, Bernotiene E, Jarmalaite S. Daniunaite K, et al. Mol Cell Biochem. 2015 Dec;410(1-2):111-20. doi: 10.1007/s11010-015-2543-7. Epub 2015 Aug 26. Mol Cell Biochem. 2015. PMID: 26307369
Heterogeneity of DNA methylation in multifocal prostate cancer.
Serenaite I, Daniunaite K, Jankevicius F, Laurinavicius A, Petroska D, Lazutka JR, Jarmalaite S. Serenaite I, et al. Among authors: daniunaite k. Virchows Arch. 2015 Jan;466(1):53-9. doi: 10.1007/s00428-014-1678-3. Epub 2014 Nov 5. Virchows Arch. 2015. PMID: 25369892
Prognostic value of RASSF1 promoter methylation in prostate cancer.
Daniunaite K, Jarmalaite S, Kalinauskaite N, Petroska D, Laurinavicius A, Lazutka JR, Jankevicius F. Daniunaite K, et al. J Urol. 2014 Dec;192(6):1849-55. doi: 10.1016/j.juro.2014.06.075. Epub 2014 Jun 26. J Urol. 2014. PMID: 24980613